Literature DB >> 26408724

Endometrial Carcinoma Associated with Ovarian Granulosa Cell Tumors--A Case Report.

Nicolae Bacalbasa1, Claudia Stoica2, Ileana Popa3, Gratiela Mirea2, Irina Balescu4.   

Abstract

Ovarian granulosa cell tumors represent uncommon neoplasms with estrogen-secreting capacity. Due to their association with persistently increased levels of estrogen, modifications of the endometrial tissue ranging from hyperplasia to malignant degeneration may be encountered. We present the case of a 65-year-old patient who presented for post-menopausal vaginal bleeding. The endometrial biopsy raised the suspicion of an atypical endometrial hyperplasia and the patient was submitted to surgery. Histopathological studies of the specimen of total hysterectomy with bilateral adnexectomy revealed the presence of a well-differentiated endometrial carcinoma associated with a granulosa cell tumor of the ovary. In conclusion whenever a modified aspect of the endometrium is found preoperatively, attention should be given on other possible underlying modifications and a radical approach should be taken in consideration. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Endometrial carcinoma; granulosa cell tumor of the ovary; total hysterectomy with bilateral adnexectomy

Mesh:

Year:  2015        PMID: 26408724

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  EUS-FNA Diagnosis of a Metastatic Adult Granulosa Cell Tumor in the Stomach.

Authors:  Ilias P Nikas; Athanasia Sepsa; Evangelia Kleidaradaki; Charitini Salla
Journal:  Lab Med       Date:  2022-09-01

Review 2.  Synchronous Cervical Adenocarcinoma and Ovarian Serous Adenocarcinoma-A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Irina Cecilia Balescu; Camelia Diaconu; Simona Dima; Laura Iliescu; Mihaela Vilcu; Alexandru Filipescu; Ioana Halmaciu; Dragos Cretoiu; Iulian Brezean
Journal:  Medicina (Kaunas)       Date:  2020-03-29       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.